InsiderTrades

Form 4 for PRVA Privia Health Group, Inc.

Accepted 2022-07-08 00:00:00 ET · period of report 2022-07-07 · accession 0001759655-22-000091 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-07-08 2022-07-07 PRVA Mountcastle David EVP, CFO S - Sale+OE $32.35 -1,212 92.7K -1% -$39.2K
D 2022-07-08 2022-07-07 PRVA Mountcastle David EVP, CFO M - OptEx $2.00 +2,492 93.9K +3% +$4,984
D 2022-07-08 2022-07-07 PRVA Mountcastle David EVP, CFO M - OptEx $0.00 -2,492 15.4K -14% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-07-07 S D 1,212 $32.35 92,651 D — —
2 Common Common Stock 2022-07-07 M A 2,492 $2.00 93,863 D — —
3 Derivative Stock Option (Right to Purchase) 2022-07-07 M D 2,492 $0.00 15,369 D $2.00 · — to 2029-12-03 2,492 Common Stock (F2) Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 8,930 of the stock options are fully vested and exercisable. 6,438 of the stock options will vest on October 29, 2022 and 2,493 of the stock options will vest December 4, 2022.